Saudi Arabia Diabetes Drug Market Analysis, Outlook & Growth Rate 2030

 


Overview of the Saudi Arabia Diabetes Drug Market:

The Saudi Arabia Diabetes Drug Market reports delivers an in-depth assessment of market size, share, and emerging trends, offering valuable insights into growth opportunities. It examines market segmentation and definitions, highlighting core components and key drivers of expansion. By applying SWOT and PESTEL analyses, the study evaluates the sector's strengths, weaknesses, opportunities, and threats, while also considering political, economic, social, technological, environmental, and legal factors. Expert reviews of competitor strategies and recent developments provide a clearer view of regional dynamics and future market trajectories, establishing a strong foundation for strategic planning and informed investment decisions.  

What will be the market size of Saudi Arabia Diabetes Drug market 2030?

The  Saudi Arabia Diabetes Drug Market  size was valued at around  USD 2 billion in 2024  and is projected to reach  USD 3.4 billion by 2030 . Along with this, the market is estimated to grow at a  CAGR  of around 9% during the forecast period (2025-30).   

Download Free PDF Brochure:  https://www.marknteladvisors.com/query/request-sample/saudi-arabia-diabetes-drug-market.html

Who are the top companies operating in the Saudi Arabia Diabetes Drug market?

The report features prominent companies operating in the Saudi Arabia Diabetes Drug market and the successful strategies they have adopted. It also provides detailed insights into each company's market share and their role in driving the industry's growth. As per MarkNtel Advisors , top companies in Saudi Arabia Diabetes Drug market : Novo Nordisk A/S, Takeda, Pfizer, Eli Lilly, Janssen Pharmaceuticals, Astellas, Boehringer Ingelheim, Merck and Co., AstraZeneca, Julphar, Bristol Myers Squibb, Novartis, Sanofi Aventis, and others    

What is the key factor projected to fuel growth in the Saudi Arabia Diabetes Drug Market between 2025 and 2030?

High Prevalence of Diabetes Propelling Market Growth –  Due to genetic predispositions and unhealthy lifestyle choices, Saudi Arabia has one of the highest prevalence rates in the world. By 2026, around 24% of the total adult population of Saudi Arabia is expected to have Diabetes which was just around 17.7% in 2021. This rising prevalence is leading the nation to become the 2nd highest in the Middle East and 7th highest globally in diabetes occupancy. An unhealthy lifestyle has resulted in the prevalence of obesity-related problems in Saudi Arabia that mainly poses a threat to several chronic diseases like Type-2 diabetes. An approximate 35.4% of the adult population of Saudi Arabia suffers from obesity. This creates an immense nationwide demand for Diabetes Drugs for the treatment and prevention of diabetes, thereby significantly contributing to the market growth.

Another reason is the country has some of the highest per capita consumption of sugar-filled drinks which worsens the diabetes epidemic. High prevalence rates of the disease result from this sort of sedentary behavior allied with diets full of fat and sugar which fuels the growth of the Saudi Arabia Diabetes Drug Market.

Saudi Arabia Diabetes Drug Market – Segmentation Analysis

  • By Insulins (Basal [Lantus {Insulin Glargine}, Levemir {Insulin Detemir}, Toujeo{Insulin Glargine}, Tresiba{Insulin Degludec}, Basaglar {Insulin Glargine}), Bolous [NovoRapid/Novolog {Insulin Aspart}, Humalog {Insulin Lispro}, Apidra {Insulin Glulisine}], Traditional Insulins [Novolin/ ​​Actrapid/Insulatard, Humulin, Insuman], Biosimilar Insulins [Insulin Glargine Biosimilars, Human Insulin Biosimilars)]
  • By Oral Anti-Diabetic Drugs (Biguanides [Metformin], Alpha-Glucosidase Inhibitors, Dopamine D2 receptor agonist [Bromocriptin], SGLT-2 Inhibitors [Invokana {Canagliflozin}, Jardiance {Empagliflozin}, Farxiga/Forxiga {Dapagliflozin}, Suglat {Ipragliflozin}], DPP-4 Inhibitors [Onglyza {Saxagliptin}, Tradjenta {Linagliptin}, Vipidia/Nesina{Alogliptin}, Galvus {Vildagliptin}], Sulphonylureas, Meglitinides)
  • By Non-Insulin Injection Drugs (GLP-1 Receptor Agonists [Victoza {Liraglutide}, Byetta {Exenatide}, Bydureon {Exenatide}, Trulicity {Dulaglutide}, Lyxumia {Lixisenatide}], Amylin Analogue [Symlin {Pramlintide}])
  • By Combination Drugs (Insulin Combinations [NovoMix {Biphasic Insulin Aspart}, Ryzodeg {Insulin Degludec and Insulin Aspart}, Xultophy {Insulin Degludec and Liraglutide}], Oral Combinations [Janumet {Sitagliptin and Metformin}])
  • By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Clinics and Diabetes Centers) and Others

Browse Full Research Report:  https://www.marknteladvisors.com/research-library/saudi-arabia-diabetes-drug-market.html

This Section cover detailed analysis of revenue, market share and growth rate, historical data (2020-23) and forecast (2025-2030) of the following segmentation and geography.

Comprehensive Table of Contents – Saudi Arabia Diabetes Drug Market Analysis and Forecast, 2030

  1. Table 1:  Introduction
  2. Table 2:  Executive Summary
  3. Table 3:  Market Regulations, Policies & Standards
  4. Table 4:  Saudi Arabia Diabetes Drug Market Size, Share & Scope, 2020-2030F
  5. Table 5:  Market Trends & Developments
  6. Table 6:  Market Dynamics (Key Drivers, and Challenges)
  7. Table 7:  Market Hotspots & Opportunities
  8. Table 8:  Market Value Chain Analysis
  9. Table 9:  Market Outlook, 2020-2030F
  10. Table 10:  Market Size & Analysis by Revenues (USD Million) : 
  11. Table 11:  Market Size & Forecast 2020–2030 by Segmentation
  12. Table 12:  Market Size & Forecast 2020–2030 by Geography
  13. Table 13:  Key Strategic Imperatives for Success & Growth
  14. Table 14:  Competitor Analysis of Saudi Arabia Diabetes Drug Companies

Inquire Before Buying, Connect with our Expertise Today:  https://www.marknteladvisors.com/query/talk-to-our-consultant/saudi-arabia-diabetes-drug-market.html

Key Benefits for Industry Participants and Stakeholders

  • Insight into emerging market trends and investment opportunities
  • Understanding of regional market dynamics and competitive landscapes
  • Data-driven forecasts to support strategic decision-making
  • Access to industry benchmarks for performance evaluation
  • Identification of potential risks and growth challenges

Browse More Reports:

About Us:

MarkNtel Advisors is a leading consulting, data analytics, and  market research firm  that provides an extensive range of strategic reports on diverse industry verticals. We being a  qualitative & quantitative research company , strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research  across 80+ countries , spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us:

MarkNtel Advisors

Office No. 109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Contact No:  +91 8719999009

Email:  sales@marknteladvisors.com

Commentaires

Enregistrer un commentaire

Posts les plus consultés de ce blog

Saudi Arabia Polyvinyl Chloride (PVC) Market Outlook: Size, Share, and Competitive Trends 2028

Image
Overview of the Saudi Arabia Polyvinyl Chloride (PVC) Industry: The  Saudi Arabia Polyvinyl Chloride (PVC) market   is projected to experience substantial growth between 2023 and 2028, driven by digital transformation, innovation in service delivery, and expanding demand. With a forecasted  CAGR  of  4.5%  during the forecast period, ie,  2023-28. This report offers an in-depth analysis of the key drivers, challenges, competitive landscape, and future outlook — helping businesses, investors, and stakeholders make informed decisions. Market Size & Forecast (2023–2028) Base Year:  2022 Forecast Period:  2023-28 Estimated CAGR (2023-28):  4.5% Key Market Driver (What's Driving Saudi Arabia Polyvinyl Chloride (PVC) Sector Growth?) Surging Construction of Residential Building to Lead the Market Growth  – During the historical period, the residential sector experienced notable growth due to the increasing construction of ho...
Lire la suite

Turkey Tire Market Forecast, and Industry Overview 2027

Image
  Overview of the Turkey Tire Industry: The Turkey Tire Market   is projected to experience substantial growth between 2022 and 2027, driven by digital transformation, innovation in service delivery, and expanding demand. With a forecasted CAGR of 3.45% during the forecast period, ie, 2022-27. This report offers an in-depth analysis of the key drivers, challenges, competitive landscape, and future outlook — helping businesses, investors, and stakeholders make informed decisions. Market Size & Forecast (2022–2027) Base Year:  2021 Forecast Period:  2022-27 Estimated CAGR (2022-27):  3.45% Key Market Driver (What's Driving Turkey Tire Sector Growth?) Swift Expansion of the Commercial Sector - With rapid infrastructural developments, Turkey is witnessing a swift expansion of its commercial sector, exhibiting the construction of hospitals, hotels, educational institutions, office spaces, among others. It, in turn, is boosting the demand for heav...
Lire la suite

Automotive Lubricants Industry Share, Size, and Competitive Landscape 2028

Image
  Overview of the Automotive Lubricants Industry: The Automotive Lubricants market is projected to experience substantial growth between 2023 and 2028, driven by digital transformation, innovation in service delivery, and expanding demand. With a forecasted CAGR of  5.0% during the forecast period, ie, 2023-28.             This report offers an in-depth analysis of the key drivers, challenges, competitive landscape, and future outlook — helping businesses, investors, and stakeholders make informed decisions. Market Size & Forecast (2023–2028) Base Year:  2022 Forecast Period:  2023-28 Estimated CAGR (2023-28):  5.0% Key Market Driver (What's Driving Automotive Lubricants Sector Growth?) Expansion of the Automotive Industry Presenting the Demand for Frequent Lubrication -   The automotive industry is expanding with the rise in disposable income, the addition of advanced features, and consumer desire to own a passenger...
Lire la suite